The virtual house call: A 21st-century innovation in the care of patients with Parkinson disease.

Shprecher DR, Majersik JJ.

Neurology. 2017 Sep 12;89(11):1103-1104. doi: 10.1212/WNL.0000000000004366. Epub 2017 Aug 16. No abstract available.

Impaired frontal lobe functions in patients with Parkinson's disease and psychosis.

Thota N, Lenka A, George L, Hegde S, Arumugham SS, Prasad S, Stezin A, Kamble N, Yadav R, Pal PK.

Asian J Psychiatr. 2017 Dec;30:192-195. doi: 10.1016/j.ajp.2017.10.013. Epub 2017 Oct 28.

Dopaminergic and non-dopaminergic gait components assessed by instrumented timed up and go test in Parkinson's disease.

Dibilio V, Nicoletti A, Mostile G, Toscano S, Luca A, Raciti L, Sciacca G, Vasta R, Cicero CE, Contrafatto D, Zappia M.

J Neural Transm (Vienna). 2017 Oct 10. doi: 10.1007/s00702-017-1794-8. [Epub ahead of print]

Parkinson's disease-associated receptor GPR37 is an ER chaperone for LRP6.

Berger BS, Acebron SP, Herbst J, Koch S, Niehrs C.

EMBO Rep. 2017 Mar 24. pii: e201643585. doi: 10.15252/embr.201643585. [Epub ahead of print]

Pronation and supination analysis based on biomechanical signals from Parkinson's disease patients.

Garza-Rodríguez A, Sánchez-Fernández LP, Sánchez-Pérez LA, Ornelas-Vences C, Ehrenberg-Inzunza M.

Artif Intell Med. 2017 Oct 14. pii: S0933-3657(17)30103-3. doi: 10.1016/j.artmed.2017.10.001. [Epub ahead of print]

Modulation of Parkinson's Disease Associated Protein Rescues Alzheimer's Disease Degeneration.

Nunomura A, Zhu X, Perry G.

J Alzheimers Dis. 2017;55(1):73-75.

Cognitive complaint in early Parkinson's disease: A pilot study.

Dupouy J, Ory-Magne F, Mekies C, Rousseau V, Puel M, Rerat K, Pariente J, Brefel-Courbon C; PARKMIP group..

Acta Neurol Scand. 2017 Aug 22. doi: 10.1111/ane.12808. [Epub ahead of print]

Parkinson's disease; the hibernating spore hypothesis.

Berstad K, Berstad JER.

Med Hypotheses. 2017 Jul;104:48-53. doi: 10.1016/j.mehy.2017.05.022. Epub 2017 May 26.

β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity.

Huang L, Deng M, Zhang S, Lu S, Gui X, Fang Y.

Biomed Pharmacother. 2017 Aug 5;94:666-678. doi: 10.1016/j.biopha.2017.07.125. [Epub ahead of print]

Benefit from the Chin-Down Maneuver in the Swallowing Performance and Self-Perception of Parkinson's Disease Patients.

Ayres A, Jotz GP, Rieder CR, Olchik MR.

Parkinsons Dis. 2017;2017:7460343. doi: 10.1155/2017/7460343. Epub 2017 Jan 19.

Backward compared to forward over ground gait retraining have additional benefits for gait in individuals with mild to moderate Parkinson's disease: A randomized controlled trial.

Grobbelaar R, Venter R, Welman KE.

Gait Posture. 2017 Aug 18;58:294-299. doi: 10.1016/j.gaitpost.2017.08.019. [Epub ahead of print]

Caffeine as symptomatic treatment for Parkinson disease (Café-PD): A randomized trial.

Postuma RB, Anang J, Pelletier A, Joseph L, Moscovich M, Grimes D, Furtado S, Munhoz RP, Appel-Cresswell S, Moro A, Borys A, Hobson D, Lang AE.

Neurology. 2017 Sep 27. pii: 10.1212/WNL.0000000000004568. doi: 10.1212/WNL.0000000000004568. [Epub ahead of print]

Plasma levels of miR-137 and miR-124 are associated with Parkinson's disease but not with Parkinson's disease with depression.

Li N, Pan X, Zhang J, Ma A, Yang S, Ma J, Xie A.

Neurol Sci. 2017 Feb 8. doi: 10.1007/s10072-017-2841-9. [Epub ahead of print]

Aggregation of α-Synuclein in the Gonadal Tissue of 2 Patients With Parkinson Disease.

Garrido A, Aldecoa I, Gelpi E, Tolosa E.

JAMA Neurol. 2017 Mar 13. doi: 10.1001/jamaneurol.2016.6155. [Epub ahead of print] No abstract available.

Treatment of a female patient with persistent genital arousal and Parkinson's disease with paliperidone.

Fountoulakis KN, Tegos T, Goulis DG, Nimatoudis I, Kimiskidis V.

Aust N Z J Psychiatry. 2017 Jan;51(1):98-99. doi: 10.1177/0004867416660200. No abstract available.